Format

Send to

Choose Destination
Methods Mol Biol. 2008;431:271-83.

Target-based antimicrobial drug discovery.

Author information

1
Wyeth Research, Pearl River, NY, USA.

Abstract

The continued increase in antibiotic resistance among bacterial pathogens, coupled with a decrease in infectious disease research among pharmaceutical companies, has escalated the need for novel and effective antibacterial chemotherapies. While current agents have emerged almost exclusively from whole-cell screening of natural products and small molecules that cause microbial death, recent advances in target identification and assay development have resulted in a flood of target-driven drug discovery methods. Whether genome-based methodologies will yield new classes of agents that conventional methods have been unable to is yet to be seen. At the end of the day, perhaps a synergy between old and new approaches will harvest the next generation of antibacterial treatments.

PMID:
18287763
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center